A 2024 clinical study found that those who exercised and took GLP-1s like Ozempic kept weight off better and regained less weight when they stopped taking GLP-1s compared to those who didnt exercise
2 Recently, there has been a report of semaglutide increasing the risk of erectile dysfunction (ED) in men
Assessment of body composition in health and disease using bioelectrical impedance analysis (BIA) and dual energy X-ray absorptiometry (DXA): a critical overview
Semaglutide, in particular, has demonstrated strong protective benefits for brain health
Weight loss should resume if it had stalled
The most prominent drugs that target IL-17 include secukinumab (IL-17A inhibitor), a human IgG1 monoclonal antibody that was the first licensed IL-17A inhibitor for use in the EU and the US, and bimekizumab (IL-17A and IL-17F inhibitor), a humanized monoclonal antibody, currently licensed for use in the EU (1013)